Director, Business Development
Harvard University, Office of Technology Development
Daniel Behr co-founded 4 technology companies, was a general partner in a seed-stage venture fund, and has served as director and advisor to numerous start-ups commercializing medical devices, instruments, nano technologies, and software products. He is currently a venture catalyst at Harvard University where, in his role as Director of Business Development in the Office of Technology Development, he has launched several startups and negotiated a variety of licensing and research agreements. Daniel started IN USA which became a $10M world leader in ozone instrumentation; Compact Instruments, which developed the worlds first hand-held mass spectrometer and was acquired by MKS Instruments (NASDAQ:MKSI); Arradiance, which is developing an electron-beam source for use in semiconductor lithography; and Growth Point Life Sciences, a firm focused on accelerating the commercialization of intellectual property assets. His seed-stage venture fund, Seed Partners, was founded in 1999 and its portfolio includes Zipcar (car sharing), Nutfield Technology (industrial lasers), NEXX Systems (semiconductor equipment), Xceed Molecular (gene expression arrays), and Seedling (medical devices). Prior to his first startup, Daniel worked as a management consultant for Bain & Co. and as a research engineer for Albany International. He earned an MBA with Distinction from the Harvard Business School and an engineering degree with Highest Honors from Georgia Tech, and is fluent in Spanish and German.